再鼎医药(ZLAB)今日盘中大涨5.16%,股价出现明显波动。引发行情剧烈波动的主要原因是,近期有机构对这只股票进行了大笔增持。
具体来看,根据香港联交所11月19日披露的文件,机构投资者威灵顿投资管理(Wellington Management Group LLP)于11月15日以每股均价27.803美元增持再鼎医药1,012.5万股H股股份,增持金额高达约2.82亿美元。增持后,威灵顿投资管理持有再鼎医药1.01亿股股份,持仓比例从此前的9.14%提升至10.15%。
这一大笔机构增持行为显然令市场看好再鼎医药当前估值和未来业绩增长前景,推升了这只医药股的股价。同时,再鼎医药也公告将根据2024年股权激励计划向8名员工授出1.5万份限制股票单位,有助于提升公司治理水平,但这次授予数量较小,对行情影响不大。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.